Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Obesity Medicine
Should orlistat be avoided in patients with a history of kidney stones?
Related Questions
How long do you typically treat patients with phentermine for weight loss and what clinical markers do you follow?
Do you tend to avoid the use of oral weight loss stimulant medications such as phentermine in obese patients on SSRI or ADHD treatments?
What do you recommend to your patients to prevent muscle loss when prescribing a GLP-1 agonist for weight loss?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
What vitamins and minerals do you check yearly for patients post gastric bypass surgery?
How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?
In patients with iron deficiency due to history of gastric bypass or IBD, would you consider oral iron therapy if the iron deficiency anemia is mild?
Can fatty liver disease present with elevations in alkaline phosphatase without other liver enzyme elevations (AST and ALT)?
Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?
How do you decide between bariatric surgery and a GLP-1 receptor agonist for patients with metabolic dysfunction-associated steatotic liver disease who have not met weight loss goals after six months of lifestyle interventions?
